Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $34.02, but opened at $35.31. Privia Health Group shares last traded at $36.62, with a volume of 16,211 shares trading hands.
Analysts Set New Price Targets
PRVA has been the topic of a number of recent analyst reports. BTIG Research initiated coverage on Privia Health Group in a report on Thursday, April 28th. They set a “buy” rating and a $35.00 price objective on the stock. Bank of America initiated coverage on Privia Health Group in a report on Tuesday, May 3rd. They set a “buy” rating and a $27.00 price objective on the stock. Truist Financial upped their price objective on Privia Health Group from $36.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, July 14th. SVB Leerink upped their price objective on Privia Health Group from $43.00 to $44.00 and gave the stock an “outperform” rating in a report on Friday, March 25th. Finally, Guggenheim initiated coverage on Privia Health Group in a report on Tuesday, March 29th. They set a “buy” rating and a $35.00 price objective on the stock. Ten research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $38.30.
Privia Health Group Price Performance
The company has a quick ratio of 2.24, a current ratio of 2.24 and a debt-to-equity ratio of 0.07. The company has a market cap of $3.96 billion, a price-to-earnings ratio of -17.86 and a beta of 0.72. The company has a fifty day simple moving average of $28.23 and a two-hundred day simple moving average of $25.47.
Privia Health Group (NASDAQ:PRVA – Get Rating) last issued its quarterly earnings data on Thursday, May 12th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.15. Privia Health Group had a negative return on equity of 47.87% and a negative net margin of 19.80%. The business had revenue of $313.80 million for the quarter, compared to the consensus estimate of $296.36 million. On average, equities research analysts anticipate that Privia Health Group, Inc. will post -0.16 earnings per share for the current fiscal year.
Insider Activity
In other news, CFO David Mountcastle sold 1,212 shares of the company’s stock in a transaction on Thursday, July 7th. The stock was sold at an average price of $32.34, for a total value of $39,196.08. Following the sale, the chief financial officer now directly owns 92,651 shares in the company, valued at $2,996,333.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Matthew Shawn Morris sold 77,534 shares of the stock in a transaction dated Thursday, June 23rd. The stock was sold at an average price of $29.41, for a total transaction of $2,280,274.94. Following the transaction, the chief executive officer now directly owns 121,739 shares in the company, valued at $3,580,343.99. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David Mountcastle sold 1,212 shares of the stock in a transaction dated Thursday, July 7th. The stock was sold at an average price of $32.34, for a total value of $39,196.08. Following the transaction, the chief financial officer now owns 92,651 shares in the company, valued at $2,996,333.34. The disclosure for this sale can be found here. Insiders have sold 606,003 shares of company stock worth $19,177,701 over the last three months. 57.60% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Privia Health Group
Several large investors have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. purchased a new position in Privia Health Group during the fourth quarter worth about $25,000. First Horizon Advisors Inc. purchased a new position in Privia Health Group during the fourth quarter worth about $26,000. FourThought Financial LLC increased its stake in Privia Health Group by 77.2% during the first quarter. FourThought Financial LLC now owns 2,417 shares of the company’s stock worth $65,000 after acquiring an additional 1,053 shares during the last quarter. US Bancorp DE increased its stake in Privia Health Group by 8.8% during the first quarter. US Bancorp DE now owns 13,923 shares of the company’s stock worth $372,000 after acquiring an additional 1,131 shares during the last quarter. Finally, Blair William & Co. IL increased its stake in Privia Health Group by 9.2% during the first quarter. Blair William & Co. IL now owns 17,412 shares of the company’s stock worth $465,000 after acquiring an additional 1,463 shares during the last quarter. 63.77% of the stock is currently owned by hedge funds and other institutional investors.
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
See Also
Receive News & Ratings for Privia Health Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Privia Health Group and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
